353 related articles for article (PubMed ID: 30714832)
1. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
Woodard GA; Price ER
AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
[TBL] [Abstract][Full Text] [Related]
2. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.
Hofvind S; Iversen BF; Eriksen L; Styr BM; Kjellevold K; Kurz KD
Acta Radiol; 2011 Jun; 52(5):481-7. PubMed ID: 21498306
[TBL] [Abstract][Full Text] [Related]
3. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of malignancy risk stratification of microcalcifications detected on mammography: a study based on the 5th edition of BI-RADS.
Kim SY; Kim HY; Kim EK; Kim MJ; Moon HJ; Yoon JH
Ann Surg Oncol; 2015 Sep; 22(9):2895-901. PubMed ID: 25608770
[TBL] [Abstract][Full Text] [Related]
5. Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features.
Woodard GA; Ray KM; Joe BN; Price ER
Radiology; 2018 Jan; 286(1):60-70. PubMed ID: 28885890
[TBL] [Abstract][Full Text] [Related]
6. Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.
Bae MS; Moon WK; Chang JM; Cho N; Park SY; Won JK; Jeon YK; Moon HG; Han W; Park IA
Eur Radiol; 2013 Aug; 23(8):2072-8. PubMed ID: 23512196
[TBL] [Abstract][Full Text] [Related]
7. Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
Grimm LJ; Johnson DY; Johnson KS; Baker JA; Soo MS; Hwang ES; Ghate SV
Eur Radiol; 2017 Jun; 27(6):2275-2281. PubMed ID: 27752832
[TBL] [Abstract][Full Text] [Related]
8. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation.
Holland R; Hendriks JH
Semin Diagn Pathol; 1994 Aug; 11(3):181-92. PubMed ID: 7831529
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Positive Predictive Values of Categorization of Suspicious Calcifications Using the 4th and 5th Editions of BI-RADS.
Park GE; Kim SH; Lee JM; Kang BJ; Chae BJ
AJR Am J Roentgenol; 2019 Sep; 213(3):710-715. PubMed ID: 31063419
[No Abstract] [Full Text] [Related]
10. Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy?
Metaxa L; Healy NA; O'Keeffe SA
Br J Radiol; 2019 Nov; 92(1103):20190177. PubMed ID: 31365279
[TBL] [Abstract][Full Text] [Related]
11. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
[TBL] [Abstract][Full Text] [Related]
12. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
Stomper PC; Geradts J; Edge SB; Levine EG
AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
[TBL] [Abstract][Full Text] [Related]
13. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
Rauch GM; Hobbs BP; Kuerer HM; Scoggins ME; Benveniste AP; Park YM; Caudle AS; Fox PS; Smith BD; Adrada BE; Krishnamurthy S; Yang WT
Ann Surg Oncol; 2016 Feb; 23(2):482-9. PubMed ID: 26416712
[TBL] [Abstract][Full Text] [Related]
14. Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score.
Knopfelmacher A; Fox J; Lo Y; Shapiro N; Fineberg S
Mod Pathol; 2015 Sep; 28(9):1167-73. PubMed ID: 26111975
[TBL] [Abstract][Full Text] [Related]
15. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.
Jansen SA; Newstead GM; Abe H; Shimauchi A; Schmidt RA; Karczmar GS
Radiology; 2007 Dec; 245(3):684-91. PubMed ID: 18024450
[TBL] [Abstract][Full Text] [Related]
16. Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project.
Evans A; Clements K; Maxwell A; Bishop H; Hanby A; Lawrence G; Pinder SE;
Clin Radiol; 2010 Mar; 65(3):181-4. PubMed ID: 20152272
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype.
Stomper PC; Connolly JL
AJR Am J Roentgenol; 1992 Sep; 159(3):483-5. PubMed ID: 1323923
[TBL] [Abstract][Full Text] [Related]
18. Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions.
Lin CY; Mooney K; Choy W; Yang SR; Barry-Holson K; Horst K; Wapnir I; Allison K
Mod Pathol; 2018 Apr; 31(4):562-568. PubMed ID: 29243740
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients.
Kong J; Liu X; Zhang X; Zou Y
Medicine (Baltimore); 2020 Jul; 99(28):e20847. PubMed ID: 32664078
[TBL] [Abstract][Full Text] [Related]
20. Imaging for the diagnosis and management of ductal carcinoma in situ.
D'Orsi CJ
J Natl Cancer Inst Monogr; 2010; 2010(41):214-7. PubMed ID: 20956833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
